|S.No.||Company Name||Short Description||No of Drugs||Company Drug Price||Action|
|1||AbbVie||AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune diseases; IMBRUVICA, an oral therapy for treating chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, to treat adults with genotype 1 chronic hepatitis C.||4||50.00|
|S.No.||Updated On||Drug||Price in USD||Action|
|1||Mar, 2023||Humira Drug Sales & Forecast|
Humira (adalimumab) is a biologic therapy administered as a subcutaneous injection. It is approved to treat the following autoimmune diseases such as rheu....
|2||Jun, 2020||AdroGel Drug Sales |
AndroGel (testosterone gel) is a testosterone replacement therapy for males diagnosed with symptomatic low testosterone due to certain underlying conditio....
|3||Jun, 2020||Creon Drug Sales & Forecast|
Creon (pancrelipase) is a pancreatic enzyme therapy for exocrine pancreatic insufficiency, a condition that occurs in patients with cystic fibrosis, chron....
|4||Jun, 2020||Viekira Pak Drug Sales |
Viekira Pak is an all-oral, short-course, interferon-free therapy, with or without ribavirin, for the treatment of adult patients with genotype 1 chronic ....